Assignee
IDEC PHARMACEUTICALS
US·0 granted patents·2 pending applications·0 citations·filing 2002–2002
Top patents by PatentIndex Score
2 records- 0148US2003180292A1Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapyIDEC PHARMACEUTICALS·Filed 2002·Application pending·0 cites
- 0248US2003082172A1Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphomaIDEC PHARMACEUTICALS·Filed 2002·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →